Bryn Mawr, PA, United States of America

Emilie J B Calvello

This inventor holds 3 USPTO granted patents. Top assignee: Bristol-Myers Squibb Pharma Company. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emilie J B Calvello. Retrieved from https://idiyas.com/inventor/emilie-j-b-calvello

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.9

ph-index = 3

Forward Citations = 380(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Emilie J B Calvello: Innovator in Pharmaceutical Chemistry

Introduction

Emilie J B Calvello is a distinguished inventor based in Bryn Mawr, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on innovative compounds that have the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents are the "Substituted heterocycle fused gamma-carbolines." This invention showcases his expertise in developing novel chemical structures that may lead to new drug formulations.

Career Highlights

Emilie is currently employed at Bristol-Myers Squibb Pharma Company, where he continues to advance his research and development efforts. His role at this prominent pharmaceutical company allows him to collaborate with other leading scientists in the industry.

Collaborations

Throughout his career, Emilie has worked alongside notable colleagues such as Albert Jean Robichaud and Taekyu Lee. These collaborations have further enriched his research and contributed to the success of his projects.

Conclusion

Emilie J B Calvello is a prominent figure in the field of pharmaceutical innovation, with a focus on developing new chemical compounds. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…